[HTML][HTML] Fluorescent parallel electrophoresis assay of enzyme inhibition
LD Casto-Boggess, LA Holland - Analytica Chimica Acta, 2024 - Elsevier
Background Enzyme inhibitors comprise the largest class of pharmaceutical compounds.
The discovery and development of new enzyme inhibitor drug candidates depends on …
The discovery and development of new enzyme inhibitor drug candidates depends on …
Fluorescent parallel electrophoresis assay of enzyme inhibition.
LD Casto-Boggess, LA Holland - Analytica Chimica Acta, 2024 - europepmc.org
Background Enzyme inhibitors comprise the largest class of pharmaceutical compounds.
The discovery and development of new enzyme inhibitor drug candidates depends on …
The discovery and development of new enzyme inhibitor drug candidates depends on …
Fluorescent parallel electrophoresis assay of enzyme inhibition
LD Casto-Boggess, LA Holland - Analytica Chimica Acta, 2024 - ui.adsabs.harvard.edu
Background. Enzyme inhibitors comprise the largest class of pharmaceutical compounds.
The discovery and development of new enzyme inhibitor drug candidates depends on …
The discovery and development of new enzyme inhibitor drug candidates depends on …
Fluorescent parallel electrophoresis assay of enzyme inhibition
LD Casto-Boggess, LA Holland - Analytica chimica acta, 2024 - pubmed.ncbi.nlm.nih.gov
Background Enzyme inhibitors comprise the largest class of pharmaceutical compounds.
The discovery and development of new enzyme inhibitor drug candidates depends on …
The discovery and development of new enzyme inhibitor drug candidates depends on …